Showing results (1291-1300 of 3,660) with videos related to
Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|June 27, 2017
A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18Hongliang Chen, Kejin Wu, Maoli Wang, et al.Breast (Edinburgh, Scotland)|February 18, 2010
Pre-operative MRI for women with newly diagnosed breast cancer: perspectives on clinician and patient decision-making when evidence is uncertainKirsten J McCaffery, Jesse JansenBreast (Edinburgh, Scotland)|June 19, 2017
Patient reported outcomes of autologous fat grafting after breast cancer surgeryA W W Brown, M Kabir, K A Sherman, et al.Breast (Edinburgh, Scotland)|June 19, 2017
Impact of physical activity in group versus individual physical activity on fatigue in patients with breast cancer: A pilot studyChristine Desbiens, Myriam Filion, Marie-Chantale Brien, et al.Breast (Edinburgh, Scotland)|June 20, 2017
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validationLuisa Carbognin, Isabella Sperduti, Alessandra Fabi, et al.Breast (Edinburgh, Scotland)|June 21, 2017
Rationale for immunological approaches to breast cancer therapyGwennaëlle C Monnot, Pedro RomeroBreast (Edinburgh, Scotland)|February 20, 2010
Intravenous versus oral vinorelbine plus capecitabine as second-line treatment in advanced breast cancer patients. A retrospective comparison of two consecutive phase II studiesVito Lorusso, Saverio Cinieri, Marianna Giampaglia, et al.Breast (Edinburgh, Scotland)|February 23, 2010
The rise and fall in menopausal hormone therapy and breast cancer incidenceClaudio Pelucchi, Fabio Levi, Carlo La VecchiaBreast (Edinburgh, Scotland)|February 23, 2010
A vision to optimise the management of primary breast cancer in older womenK L Cheung, D A L Morgan, L Winterbottom, et al.Breast (Edinburgh, Scotland)|June 7, 2017
The emerging world of breast cancer immunotherapyMark R Nathan, Peter SchmidPageof 366